laboratori corpor
remain bullish lh follow upbeat manag meet focus
solid underli trend recent unh/aet contract pama patient
access/engag initi cro opportun capit deploy
on-going reimburs pressur pama expect
continu push toward vbc view lh well posit on-going market
share gain potenti acceler view compani
busi model differenti financi flexibl high strateg
posit enviabl reiter buy pt ep
growth lever bolster lab biz remain upbeat core
clinic lab busi see number area on-going growth
expect continu strength sever key area women health
companion diagnost see opportun around health
system partnership think launch home self-collect devic
expect year-end could offer cost/conveni benefit present
intrigu growth opportun addit applaud lh on-going progress
aim improv patient access/engag labcorp express roll
psc year-end walgreen hold collabor
continu see initi success add locat mobil app reduc
oper friction/improv user experi final continu view
intern diagnost busi attract sizabl
opportun time view partnership unilab ulab
nr intrigu
comment recent aetna/unit contract guy win move
acknowledg open aet network expect
near term headwind view contract structur encourag
view move toward valu base care meaning posit
analyt broad servic offer cost effect increas connect
view compani superbl posit market share gainer
forese futur
cro offer posit cro busi continu produc
solid trend strong rfp activ sizabl backlog addit
compani built leadership team continu gain
traction area bolster chiltern acquisit
tr target
laboratori corpor america hold
trend comprehens servic offer differenti it/data capabl reson lastli
project launchpad initi continu make headway improv operations/effici
drive on-going margin expans balanc final biotech/
pharma fund level robust cro market look pois growth
pama updat estim assum step pressur pama
continu pressur acla/cm lawsuit remain judici review regardless
outcom continu view larg independ best posit weather potenti on-going
reimburs pressur given scale margin profil modest rel exposur also see
potenti ramp view lh well posit given compani strong high
flexibl high fine tune estim net ebitda
includ proce covanc food solut sold free
expect lh financi flexibl remain high robust pipelin think
could expand pama pressur remain on-going view lh well posit augment
core growth capit deploy estim stand
respect estim assum modest activ could prove overli
conserv fine tune ep
reflect modestli conserv assumpt lower jump point
estim reiter buy rate target
page
laboratori corpor america hold
servic
revenu
incom equiti invest
revenu
laboratori corpor america mm
page
laboratori corpor america hold
headquart burlington nc laboratori corpor america hold labcorp one
largest independ clinic laboratori broad offer includ routin test
blood chemistri urinalys pap hiv substance-abus etc specialti test oncolog hiv
genotyp phenotyp diagnost genet clinic research trial compani also
opper cro busi extend servic offer includ clinic research provid
meaning intern presenc recent chiltern acquisit expand cro servic
clinic lab remain integr part healthcar deliveri model diagnost test critic
compon treatment decis process combin covanc busi lh boast
signific scale divers servic offer uniqu posit area person medicin
potenti risk-bas reimburs system diversifi revenu stream custom
base also meaning lower reimburs risk one custom repres revenu
govern pay addit signific clinic horsepow geograph
diversif provid platform addit growth opportun time
valuat risk
price target base stock trade adjust ep premium
current multipl industri peer hold given labcorp sizabl esoter presenc
solid cash flow gener attract cross-sel opportun covance/chiltern view
appropri addit believ effici initi aggress focu cost
control could provid support risk rate price target includ advers shift
reimburs pama poor integr acquisit pressur econom uncertainti
perform covanc increas competit
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
